The FDA says patients may be overdosing on imitation semaglutide weight-loss drugs because the directions are unclearConsumers overdosing on knock-off semaglutide weight-loss drugs.
FDA Says People Are Taking 20 Times the Proper Dose of Ozempic and OverdosingPeople are excited about weight loss potential of semaglutide but need caution on proper dosing to avoid adverse effects.
Unlicensed Ozempic Alternatives Are Leading to OverdosesGray market alternatives to Ozempic and Wegovy pose serious risks, including overdosing. FDA warns of potential ill effects of compounded semaglutide.
It's about to get a lot harder to buy knock-off OzempicCompounded tirzepatide offers immediate weight-loss benefits but will soon be unavailable due to FDA restrictions.
The FDA says patients may be overdosing on imitation semaglutide weight-loss drugs because the directions are unclearConsumers overdosing on knock-off semaglutide weight-loss drugs.
FDA Says People Are Taking 20 Times the Proper Dose of Ozempic and OverdosingPeople are excited about weight loss potential of semaglutide but need caution on proper dosing to avoid adverse effects.
Unlicensed Ozempic Alternatives Are Leading to OverdosesGray market alternatives to Ozempic and Wegovy pose serious risks, including overdosing. FDA warns of potential ill effects of compounded semaglutide.
It's about to get a lot harder to buy knock-off OzempicCompounded tirzepatide offers immediate weight-loss benefits but will soon be unavailable due to FDA restrictions.
Drugmakers can keep making off-brand weight-loss drugs as FDA backpedalsThe FDA's decision to change a prior ruling alleviated patient access issues but raised safety concerns regarding compounded drugs.
A Major GLP-1 Drug Shortage Is Over. Some Patients Aren't CelebratingThe end of tirzepatide shortage brings uncertainty for patients reliant on compounded versions of the drug.Patients fear losing access to effective medication due to shortages, complicating the availability situation.
Drugmakers can keep making off-brand weight-loss drugs as FDA backpedalsThe FDA's decision to change a prior ruling alleviated patient access issues but raised safety concerns regarding compounded drugs.
A Major GLP-1 Drug Shortage Is Over. Some Patients Aren't CelebratingThe end of tirzepatide shortage brings uncertainty for patients reliant on compounded versions of the drug.Patients fear losing access to effective medication due to shortages, complicating the availability situation.
People are overdosing on injectable weight-loss drugs, FDA warnsDosing errors with compounded weight-loss products resulted in overdoses, leading to severe symptoms and hospitalization.
Torrid market for copycat weight loss drugs could be short-livedOff-brand weight loss drugs containing active ingredients of popular drugs are available at lower costs but are not generics, requiring prescriptions and facing looser regulation.